Headache Center: Migraine research, migraine diagnostics, migraine therapy, headache research, headache diagnostics and headache therapy
Botulinum toxin for chronic migraine approved by the BfArM
The drug Botox® (botulinum toxin type A) was approved on September 23, 2011, for the relief of symptoms of chronic migraine in adults who have not responded adequately to prophylactic migraine treatments or [...]


_04-320x202.jpg)